SE8402727L - Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on - Google Patents

Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Info

Publication number
SE8402727L
SE8402727L SE8402727A SE8402727A SE8402727L SE 8402727 L SE8402727 L SE 8402727L SE 8402727 A SE8402727 A SE 8402727A SE 8402727 A SE8402727 A SE 8402727A SE 8402727 L SE8402727 L SE 8402727L
Authority
SE
Sweden
Prior art keywords
carbamyl
cyano
preparing
bipyridin
picoline
Prior art date
Application number
SE8402727A
Other languages
English (en)
Other versions
SE452764B (sv
SE8402727D0 (sv
Inventor
K O Gelotte
Jr C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8402727L publication Critical patent/SE8402727L/sv
Publication of SE8402727D0 publication Critical patent/SE8402727D0/sv
Publication of SE452764B publication Critical patent/SE452764B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8402727A 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on SE452764B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (3)

Publication Number Publication Date
SE8402727L true SE8402727L (sv) 1984-05-21
SE8402727D0 SE8402727D0 (sv) 1984-05-21
SE452764B SE452764B (sv) 1987-12-14

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten

Country Status (28)

Country Link
US (1) US4264609A (sv)
JP (1) JPS56128758A (sv)
KR (2) KR840002067B1 (sv)
AR (1) AR230630A1 (sv)
AT (2) AT380237B (sv)
AU (1) AU541644B2 (sv)
BE (1) BE887663A (sv)
CA (1) CA1128523A (sv)
CH (1) CH647509A5 (sv)
DE (1) DE3107306A1 (sv)
DK (1) DK171253B1 (sv)
ES (1) ES499776A1 (sv)
FI (1) FI76787C (sv)
FR (1) FR2476646A1 (sv)
GB (1) GB2070600B (sv)
HK (1) HK71789A (sv)
IE (1) IE51696B1 (sv)
IL (1) IL62161A (sv)
IT (1) IT1210992B (sv)
LU (1) LU83169A1 (sv)
MX (1) MX6908E (sv)
NL (1) NL192109C (sv)
NO (1) NO156689C (sv)
NZ (1) NZ196282A (sv)
PH (2) PH19904A (sv)
PT (1) PT72573B (sv)
SE (2) SE437514B (sv)
ZA (1) ZA811124B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77817T1 (de) 1985-04-30 1992-07-15 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NO810639L (no) 1981-08-27
ATA88581A (de) 1985-09-15
FI76787C (sv) 1988-12-12
MX6908E (es) 1986-11-07
IT1210992B (it) 1989-09-29
IT8119952A0 (it) 1981-02-24
AT380236B (de) 1986-04-25
CA1128523A (en) 1982-07-27
FI76787B (fi) 1988-08-31
PT72573B (en) 1982-02-12
DK83981A (da) 1981-08-27
SE8101205L (sv) 1981-08-27
PT72573A (pt) 1981-03-01
NL8100922A (nl) 1981-09-16
CH647509A5 (fr) 1985-01-31
FI810582L (fi) 1981-08-27
DK171253B1 (da) 1996-08-12
NL192109B (nl) 1996-10-01
US4264609A (en) 1981-04-28
IL62161A (en) 1984-06-29
FR2476646B1 (sv) 1984-08-17
SE452764B (sv) 1987-12-14
DE3107306A1 (de) 1981-12-17
FR2476646A1 (fr) 1981-08-28
IL62161A0 (en) 1981-03-31
PH17145A (en) 1984-06-04
IE810397L (en) 1981-08-26
JPH0141626B2 (sv) 1989-09-06
DE3107306C2 (sv) 1990-11-29
IE51696B1 (en) 1987-02-18
ZA811124B (en) 1982-03-31
NL192109C (nl) 1997-02-04
AU541644B2 (en) 1985-01-17
NO156689C (no) 1987-11-04
SE8402727D0 (sv) 1984-05-21
HK71789A (en) 1989-09-14
LU83169A1 (fr) 1981-09-11
JPS56128758A (en) 1981-10-08
AR230630A1 (es) 1984-05-31
NZ196282A (en) 1983-12-16
ATA305683A (de) 1985-09-15
PH19904A (en) 1986-08-13
GB2070600A (en) 1981-09-09
AU6748781A (en) 1981-09-03
GB2070600B (en) 1984-07-11
BE887663A (fr) 1981-08-25
NO156689B (no) 1987-07-27
AT380237B (de) 1986-04-25
KR840002066B1 (ko) 1984-11-09
KR830005143A (ko) 1983-08-03
SE437514B (sv) 1985-03-04
ES499776A1 (es) 1984-06-16
KR840002067B1 (ko) 1984-11-09

Similar Documents

Publication Publication Date Title
AU748352B2 (en) Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
CN101166732B (zh) 氰基吡啶衍生物及其作为药物的应用
SE8102022L (sv) Intermediat i form av 2(ih)-pyridinoner samt forfarande for framstellning derav
JP7219902B2 (ja) ブルトン型チロシンキナーゼ阻害剤
ES471526A1 (es) Procedimiento para la preparacion de derivados de acido fe- noxi-feniltio-alcan-carboxilico
JP2021504317A (ja) ハロアリルアミン類のｓｓａｏ／ｖａｐ−１阻害剤とその用途
ES8202816A1 (es) Un procedimiento para preparar diaminopiridinas
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
EP3908579A1 (en) Dihydroorotate dehydrogenase inhibitors
JP5042833B2 (ja) マクロファージエラスターゼの阻害剤としての５−［３−（４−ベンジルオキシフェニルチオ）−フラ−２−イル］−イミダゾリジン−２，４−ジオン及び類似体
JP2022516555A (ja) 線維芽細胞活性化タンパク質の阻害剤
EP3381916A1 (en) Condensed pyrimidine compound or salt thereof
SE8402727L (sv) Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on
Miki et al. Novel synthesis and 1, 3-dipolar cycloaddition reaction of pyridinium N-methylide
Dolzhenko et al. Synthesis and biological activity of fluorinated 7-benzylamino-2-phenyl-1, 2, 4-triazolo [1, 5-a][1, 3, 5] triazin-5-amines
FI74001B (fi) Foerfarande foer framstaellning av ett terapeutiskt aktivt 5-alkyl-1,6-naftyridin-2(1h)-onderivat.
US4144343A (en) Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
US4857527A (en) Morpholine containing pyridine compounds, compositions and use
KR850004756A (ko) 4,5,6,7-테트라하이드로 티아졸로[5,4-c]피리딘 유도체의 제조방법
US4156004A (en) Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, and use
MX2007014224A (es) Estirilsulfonamidas, su obtencion y uso como agentes farmaceuticos.
DE60103129D1 (de) Benzofurancarboxamide und deren therapeutische verwendung
US20150166521A1 (en) Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors
ES391492A1 (es) Procedimiento para la obtencion de ureidofenilisotioureas.
JPS60169467A (ja) 新規なフエニルピペラジン誘導体

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8402727-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8402727-5

Format of ref document f/p: F